Navigating a storm that threatens American biotechnology

David Beier
7 min readAug 26, 2022

The passage of the Inflation Reduction Act last week is an important milestone in the history of American biotechnology. I’ve been honored to participate in that history from a variety of perspectives: White House adviser, congressional staff, senior biotech executive, public company board member, lawyer, and venture capital investor.

--

--

David Beier

Managing Director, Bay City Capital, San Francisco, CA. Previously Chief Domestic Policy to Vice President Al Gore. Senior corporate officer DNA and Amgen